FLOSTAT Trademark

Trademark Overview

On Thursday, July 31, 2014, a trademark application was filed for FLOSTAT with the United States Patent and Trademark Office. The USPTO has given the FLOSTAT trademark a serial number of 86353867. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 29, 2018. This trademark is owned by Pfizer Inc.. The FLOSTAT trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations, namely, hemostatic agents; syringes sold filled with pharmaceutical preparations for hemostatic purposes
flostat

General Information

Serial Number86353867
Word MarkFLOSTAT
Filing DateThursday, July 31, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 29, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 28, 2014

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations, namely, hemostatic agents; syringes sold filled with pharmaceutical preparations for hemostatic purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 8, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, January 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 29, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, April 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2017EXTENSION 5 GRANTED
Monday, April 17, 2017EXTENSION 5 FILED
Monday, April 17, 2017TEAS EXTENSION RECEIVED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2016EXTENSION 4 GRANTED
Monday, November 21, 2016EXTENSION 4 FILED
Wednesday, December 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 21, 2016TEAS EXTENSION RECEIVED
Saturday, June 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 10, 2016EXTENSION 3 GRANTED
Wednesday, June 1, 2016EXTENSION 3 FILED
Wednesday, June 1, 2016TEAS EXTENSION RECEIVED
Tuesday, March 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 27, 2016EXTENSION 2 GRANTED
Monday, November 30, 2015EXTENSION 2 FILED
Monday, January 25, 2016ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Wednesday, December 30, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 30, 2015TEAS EXTENSION RECEIVED
Monday, November 30, 2015TEAS EXTENSION RECEIVED
Tuesday, June 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 12, 2015EXTENSION 1 GRANTED
Friday, June 12, 2015EXTENSION 1 FILED
Friday, June 12, 2015TEAS EXTENSION RECEIVED
Tuesday, December 23, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 28, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 28, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 8, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 17, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 17, 2014ASSIGNED TO EXAMINER
Friday, August 8, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 4, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

flostat preparations hemostatic pharmaceutical filled purposes sold agents namely human syringes